Ischemic Vascular Disease: LDL Cholesterol Testing
The results below represent the care of 61,773 patients with coronary and other atherosclerotic vascular disease. Read More About This Measure
There has been important evidence from clinical trials that further supports and broadens the merits of risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease.
Disclaimer: Measures reported by WCHQ healthcare
organizations represent a specific aspect of care in relation to an
evidence-based standard, but are not clinical guidelines and do not establish
standards of care.
The American College of Cardiology (ACC) and the American Heart Association (AHA) recommends that low-density lipoprotein cholesterol (LDL-C) should be < 100 mg/dL for all patients with CHD and other clinical forms of atherosclerotic disease and that patients should have one test annually, at a minimum.
This measure shows the percentage of people 18 to 75 years of age with a diagnosis of coronary or other atherosclerotic vascular disease who received an LDL-cholesterol test in the measurement year.